Literature DB >> 11061792

American Academy of Pediatrics. Committee on Child Abuse and Neglect and Committee on Bioethics. Foregoing life-sustaining medical treatment in abused children.

.   

Abstract

A decision to forego life-sustaining medical treatment (LSMT) for a critically ill child injured as the result of abuse should be made using the same criteria as those used for any critically ill child. The parent or guardian of an abused child may have a conflict of interest when a decision to forego LSMT risks changing the legal charge faced by a parent, guardian, relative, or acquaintance from assault to manslaughter or homicide. If a physician suspects that a parent or guardian is not acting in a child's best interest, further review and consultation should be sought in hopes of resolving the conflict. A guardian ad litem who will represent the child's interests regarding LSMT should be appointed in all cases in which a parent or guardian may have a conflict of interest.

Entities:  

Keywords:  American Academy of Pediatrics; Death and Euthanasia

Mesh:

Year:  2000        PMID: 11061792

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  3 in total

1.  Prevalence of questioning regarding life-sustaining treatment and time utilisation by forgoing treatment in francophone PICUs.

Authors:  Robin Cremer; Philippe Hubert; Bruno Grandbastien; Grégoire Moutel; Francis Leclerc
Journal:  Intensive Care Med       Date:  2011-08-16       Impact factor: 17.440

Review 2.  Ethical and legal considerations related to disorders of consciousness.

Authors:  Lauren Rissman; Erin Talati Paquette
Journal:  Curr Opin Pediatr       Date:  2020-12       Impact factor: 2.856

3.  Outcome and predictors for successful resuscitation in the emergency room of adult patients in traumatic cardiorespiratory arrest.

Authors:  J Zwingmann; R Lefering; M Feucht; N P Südkamp; P C Strohm; T Hammer
Journal:  Crit Care       Date:  2016-09-06       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.